ExeVio Bio is a spin-off of the Flemish Institute for Biotechnology (known by the Dutch acronym VIB). It draws on its llama nanobody technology to focus on the design of a therapeutic treatment for COVID-19 and other potential beta coronavirus-related diseases.
